Study of the Effects of the Age at Menopause and Duration of Menopause on Bone Mineral Density in Postmenopausal Women in Uzbekistan

ORIGINAL ARTICLE
Dilbar K. Najmutdinova, PhD, ScD; Lola S. Nurmukhamedova*; Dilfuza A. Alieva PhD, ScD; Dilnoza S. Maksudova PhD; Zebiniso A. Nosirova

Republican Specialized Scientific Practical Medical Center of Obstetrics and Gynecology; Tashkent, Uzbekistan

*Corresponding author: Lola S. Nurmukhamedova; E-mail: lola-ss@yandex.ru

Published: March 16, 2016. DOI: 10.21103/Article6(1)_OA7

Abstract: 

The aim of the present study was to determine whether an association exists between the duration of menopause and the age of menopause onset, and the differences in bone mineral density (BMD) in postmenopausal women.

Materials and Methods: We have reviewed medical records of 112 postmenopausal women who had not taken any anti-osteoporosis treatment and/or hormone replacement therapy at the time of BMD measurement. The mean age of the postmenopausal women was 53.5±1.1 years, and the mean menopausal period was 4.5 years. The women were evaluated according to the duration of menopause at the time of BMD measurement and age at menopause onset. BMD was measured anteroposteriorly at the L1–L4 level by the dual-energy X-ray absorptiometry method.

Results: According to WHO criteria, osteoporosis and osteopenia were identified in 18(16.2%) and 44(39.2%) cases, respectively; overall, 50(44.6%) women had normal BMD.At the time of BMD measurement, osteoporosis was determined in 10.3% and 29.1% of the women with menopause duration of 0–3 years and >7 years, respectively (P=0.047). The percentages for osteopenia were similar among the three different menopause durations (36.2%, 43.3% and 41.6% for 0-3 years, 4-7 years and >7 years, respectively). No differences were determined in the prevalence of osteopenia and osteoporosis in women with menopause duration of >7 years.Thirty-three percent of women with the age of menopause onset of <40 years had osteoporosis; however, the percentages of women with osteoporosis among the other age groups were almost equal (18.7%, 14.29% and 15.0% for 40–46 years, 47–52 years and >52 years, respectively). The frequency of osteopenia did not differ between the groups according to the age of menopause onset.

Conclusion: According to our results, osteoporosis is related to the duration of menopause at the time of BMD measurement more than to the age of menopause onset among untreated postmenopausal women.

Keywords: 
postmenopausal osteoporosis; age of menopause onset; risk factors; bone mineral density.
References: 
  1.  Poole KE, Compston JE. Osteoporosis and its management. BMJ  2006;333(7581):1251–6.
  2.  ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 50, January 2003. Obstet Gynecol. 2004; 103(1):203–216.
  3. Kanis JA, Johnell O, Oden A ,  Borgstrom F,  Zethraeus N,  De Laet C,  et al. The risk and burden of vertebral fractures in Sweden. Osteoporos Int 2004;15(1):20-6.
  4. Smetnik VP, Kulakov VI. Guide for Menopause. M: Med Inform Agentstvo; 2001. [in Russian].
  5. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et.al.  Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA.2001;286(22):2815–22.
  6. American Association of Clinical Endocrinologists (AACE) medical guidelines for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003; 9(6):544-64.
  7. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. Geneva, World Health Organization, 1994 (WHO Technical Report Series, No. 843).
  8. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137-41.
  9. Yureneva SV.  Treatment and prevention of postmenopausal osteoporosis. Consilium Medicum. 2004; 6(9):702-7.
  10. Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, Maartens LW, Keyzer JS, Weedenburg JP. The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study. Osteoporosis Int 1998; 8(5):404-9.
  11. North American Menopause Society. Management of osteoporosis in postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause. 2006;13(3):340-67.
  12. Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, et al.  Bone mineral density changes during the menopause transition in a multi-ethnic cohort of women. J Clin Endocrin Metab 2008; 93(3):861–8.
  13. Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK. Bone loss and bone size after menopause. N Engl J Med 2003; 349(4):327–34.

The fully formatted PDF version is available.

Download Article

Int J Biomed. 2016; 6(1):38-40. © 2016 International Medical Research and Development Corporation. All rights reserved.